Announcing Our Investment in Onboard AI
I’m thrilled to announce our pre-seed investment in Onboard AI. Today, the company announced it has raised $5M between the pre-seed round we co-led approximately a year ago and a new strategic partnership and investment from Cedars-Sinai, one of the nation’s leading academic medical centers.
When we first met Troy Bannister at the concept stage, his conviction around the opportunity was immediately compelling. Healthcare is experiencing an explosion of AI solutions—from clinical decision support to operational efficiency tools—with new models entering hospitals from vendors, internal projects, and enterprise tools around the clock. Yet most health systems are struggling with the governance required to safely evaluate, approve, and monitor these solutions throughout their lifecycle. Manual reviews, static checklists, and inconsistent processes have created backlogs, forcing hospitals to choose between moving too slowly or approving tools without appropriate controls.
Troy’s insight was that the best vantage point to build the industry standard for AI governance was to be early to market – even before widely adopted standards emerged. At Particle Health, which he founded, he was similarly early in healthcare data exchange, building infrastructure before the market fully recognized the need. That track record gave us conviction in his ability to execute again during another fundamental shift in healthcare.
What makes Onboard AI’s approach unique is that it’s AI-native from the ground up. The platform uses automated workflows that can read and score vendor documentation in minutes—not weeks—evaluating every AI solution for safety, accuracy, fairness, and effectiveness. This means faster approvals, reduced backlogs, and consistent standards—and Onboard AI continues monitoring AI tools throughout their lifecycle to ensure ongoing safety and compliance, all while maintaining the rigorous oversight that healthcare demands.
Since our initial investment, the team has been executing quietly with focus and speed. They’ve launched with hospital systems and payers across the industry, and the strategic partnership with Cedars-Sinai validates the approach. As Mouneer Odeh, Chief Data and AI Officer of Cedars-Sinai, puts it: “With Onboard AI, we’re scaling innovation by ensuring every solution meets our rigorous standards for safety and ethics. That’s how we build confidence in the future of healthcare.”
We’re excited to be supporting Troy and the Onboard AI team alongside our friends at Meridian Street Capital and the team at Cedars-Sinai. The opportunity to help shepherd responsible and safe use of AI to transform U.S. healthcare is enormous, and we believe Onboard AI is building the critical infrastructure layer that will enable the industry to move forward with confidence.
Blog